PCN264 - ASSESSMENT OF TREATMENTS AND HEALTH CARE UTILISATION (HCU) IN SPAIN FOLLOWING INITIAL PLATINUM THERAPY FOR RECURRENT OR METASTATIC (R/M) HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.346
https://www.valueinhealthjournal.com/article/S1098-3015(18)33646-5/fulltext
Title :
PCN264 - ASSESSMENT OF TREATMENTS AND HEALTH CARE UTILISATION (HCU) IN SPAIN FOLLOWING INITIAL PLATINUM THERAPY FOR RECURRENT OR METASTATIC (R/M) HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33646-5&doi=10.1016/j.jval.2018.09.346
First page :
Section Title :
Open access? :
No
Section Order :
2249